ECDC mission related to West Nile virus infection in Greece, 2012
Technical mission: HIV, STI and viral hepatitis in Bulgaria. 19-21 September 2016 and 14-15 November 2016
The Ministry of Health in Bulgaria invited ECDC to prepare an assessment of the current national HIV programme and to review the STI and Hepatitis surveillance system. Following discussions between ECDC and representatives of the Bulgarian national programme, it was decided to split the assessment into two separate country missions.
Mission Report, Tuberculosis in Latvia, 22 – 26 October 2012
ECDC country visit to Luxembourg to discuss antimicrobial resistance issues
An ECDC team conducted visits and meetings to the country on 29 May - 2 June 2017, with the objective of providing an evidence-based assessment of the situation. Antibiotic consumption in Luxembourg is at the EU average in hospitals, but higher than the EU average in the community. The AMR levels in bacterial isolates from humans are at or below the EU average.
ECDC country visit to Spain to discuss antimicrobial resistance issues
On 15-19 February 2016 an ECDC team conducted visits and meetings to discuss AMR issues in Spain, with the overall objective of providing an evidence-based assessment of the situation in Spain. The AMR situation in Spain poses a major public health threat to the country. Antimicrobial consumption in primary care and hospitals is among the highest in the EU/EEA and infection prevention and control and environmental cleaning measures vary significantly among hospitals and units.
ECDC country visit to Latvia to discuss antimicrobial resistance issues
As part of an ECDC country visit to Latvia on 26–30 September 2011, an ECDC team conducted visits and meetings to discuss AMR issues in Latvia and provide an assessment. Compared with many other EU countries, the present AMR situation of Latvia is favourable. There is an infection control legislation that is under implementation and the legislation is a good basis for improving infection control practices.